USANA HEALTH SCIENCES INC
For the period ended Jan 3, 2026. Filed Mar 16, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Mar 16, 2026
USNA$13.10-5.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
| Common Stock · AdditionalPaid-inCapital · RetainedEarnings · AccumulatedOtherComprehensiveIncome (Loss) · Total stockholders' equity attributable to USANA | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shares · Value | |||||||||
| Balance at December 31, 2022 | 19,206 | $19 | $55,604 | $391,636 | $(12,787) | $434,472 | |||
| Net earnings attributable to USANA | 63,788 | 63,788 | |||||||
| Other comprehensive income (loss), net of tax | (908) | (908) | |||||||
| Equity-based compensation expense | 14,595 | 14,595 | |||||||
| Common stock repurchased and retired | (180) | — | (1,446) | (10,207) | (11,653) | ||||
| Common stock issued under equity award plans | 104 | — | — | ||||||
| Tax withholding for net-share settled equity awards | (3,092) | (3,092) | |||||||
| Balance at December 30, 2023 | 19,130 | 19 | 65,661 | 445,217 | (13,695) | 497,202 | |||
| Net earnings attributable to USANA | 42,030 | 42,030 | |||||||
| Other comprehensive income (loss), net of tax | (8,975) | (8,975) | |||||||
| Equity-based compensation expense | 14,558 | 14,558 | |||||||
| Common stock repurchased and retired | (194) | — | (1,180) | (8,303) | (9,483) | ||||
| Common stock issued under equity award plans | 128 | — | — | ||||||
| Tax withholding for net-share settled equity awards | (3,223) | (3,223) | |||||||
| Balance at December 28, 2024 | 19,064 | 19 | 75,816 | 478,944 | (22,670) | 532,109 | |||
| Net earnings attributable to USANA | 10,760 | 10,760 | |||||||
| Other comprehensive income (loss), net of tax | 6,492 | 6,492 | |||||||
| Equity-based compensation expense | 13,828 | 13,828 | |||||||
| Common stock repurchased and retired | (927) | (1) | (3,753) | (23,984) | (27,738) | ||||
| Common stock issued under equity award plans | 144 | — | — | ||||||
| Tax withholding for net-share settled equity awards | (2,347) | (2,347) | |||||||
| Balance at January 3, 2026 | 18,281 | $18 | $83,544 | $465,720 | $(16,178) | $533,104 | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.